博拓生物股价异动，业绩预告与脑机接口布局引关注

Core Viewpoint - The stock price of Botao Bio experienced an increase on February 13, 2026, likely due to the company's recent earnings forecast and positive outlook for future development [1] Group 1: Earnings Performance - The company released its earnings forecast for the year 2025 on January 23, 2026, indicating a significant decline in net profit attributable to shareholders year-on-year. However, management expressed confidence in achieving steady revenue growth in 2026, supported by a stabilizing tariff environment between the US and China and the certification of differentiated competitive products in multiple markets. This "short-term performance under pressure, but future growth inflection point expected" outlook may have positively influenced market sentiment [2] Group 2: Strategic Advancement - The company's strategic positioning in the brain-computer interface sector has garnered market attention. According to reports from January 25, 2026, the company is deeply involved in the brain-computer interface industry through its investment platform and has strategically invested in related enterprises, aiming to create a second growth curve [3] Group 3: Recent Stock Performance - As of February 13, 2026, at 11:19 AM, Botao Bio's stock price rose by 5.36%, while the medical device sector index decreased by 0.18%, indicating that the company's stock performance significantly outperformed the overall sector [4]